1. Home
  2. DNLI vs DV Comparison

DNLI vs DV Comparison

Compare DNLI & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • DV
  • Stock Information
  • Founded
  • DNLI 2013
  • DV 2008
  • Country
  • DNLI United States
  • DV United States
  • Employees
  • DNLI N/A
  • DV N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • DV Computer Software: Prepackaged Software
  • Sector
  • DNLI Health Care
  • DV Technology
  • Exchange
  • DNLI Nasdaq
  • DV Nasdaq
  • Market Cap
  • DNLI 3.1B
  • DV 3.5B
  • IPO Year
  • DNLI 2017
  • DV 2021
  • Fundamental
  • Price
  • DNLI $20.73
  • DV $21.69
  • Analyst Decision
  • DNLI Strong Buy
  • DV Buy
  • Analyst Count
  • DNLI 13
  • DV 20
  • Target Price
  • DNLI $37.91
  • DV $25.53
  • AVG Volume (30 Days)
  • DNLI 814.8K
  • DV 1.2M
  • Earning Date
  • DNLI 03-04-2025
  • DV 02-27-2025
  • Dividend Yield
  • DNLI N/A
  • DV N/A
  • EPS Growth
  • DNLI N/A
  • DV 18.39
  • EPS
  • DNLI N/A
  • DV 0.38
  • Revenue
  • DNLI N/A
  • DV $638,459,000.00
  • Revenue This Year
  • DNLI N/A
  • DV $19.28
  • Revenue Next Year
  • DNLI $289.18
  • DV $12.59
  • P/E Ratio
  • DNLI N/A
  • DV $57.30
  • Revenue Growth
  • DNLI 204.74
  • DV 19.57
  • 52 Week Low
  • DNLI $14.56
  • DV $16.12
  • 52 Week High
  • DNLI $33.33
  • DV $43.00
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.56
  • DV 52.63
  • Support Level
  • DNLI $21.33
  • DV $22.40
  • Resistance Level
  • DNLI $22.81
  • DV $23.11
  • Average True Range (ATR)
  • DNLI 1.27
  • DV 0.65
  • MACD
  • DNLI -0.10
  • DV -0.04
  • Stochastic Oscillator
  • DNLI 15.83
  • DV 50.43

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. The DV Authentic Ad ensures that a digital ad was delivered in a brand-safe setting, completely viewable, by a real individual, and in the expected geography, is one of its solutions. It generates revenues from its advertisement customers by charging a Measured Transaction Fee on the volume of Media Transactions Measured on the software platform.

Share on Social Networks: